Minor-League GM Has Prostate Exam At Game Callaway Sales Up In First Half Of FY '14 Consumers Recognize World Cup Sponsors EverBank, Jaguars To Extend Deal Judge To Let Kings Arena Project Proceed Potential '24 Bid Cities Meeting With USOC TWC To Carry SEC Network At Launch NFL's Reasoning For Ray Rice Punishment UNC To Help Athletes Finish Degrees IOC Invites ISF To Host Exhibitions
Upcoming Conferences and Events
Selig, Weiner Address Biogenesis Investigation With Baseball Writers
Published July 16, 2013
Weiner outlined the matter in much more detail, saying the union is pushing to keep any public announcements of suspensions from happening until a full appeals process can be conducted. Weiner does not expect those appeals to happen before September, meaning it is unlikely the situation will have a direct on-field impact on the '13 season. "It's going to take some time – I don't know about months – for the commissioner's office to finish its investigation," he said. Weiner also said because the Biogenesis investigation delves into non-analytic positives, MLB is not necessarily bound by the 50-game/100-game/life schedule of suspensions in the joint drug agreement and conceivably could implement suspensions of various lengths.